Review paper
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Abstract
The emergence of the coronavirus 2019 (COVID-19) pandemic has presented an unprecedented global challenge. Vaccines against COVID have been developed to date. Covid-19 has been linked with the development of Guillain-Barre Syndrome (GBS), a rare immune-mediated demyelinating neuropathy. We report three cases of Guillain-Barre Syndrome and one case of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), presenting to a Tasmanian hospital,...
Paper Details
Title
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Published Date
Nov 1, 2021
Journal
Volume
360
Pages
577719 - 577719
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History